Short description
Inflammatory Response Research focuses on pharmaceutical products for the treatment of inflammatory disorders.
Description
Inflammatory Response Research is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Their initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza.
IRR was founded in 2011 and is headquartered in Santa Barbara, California.
Total funding
$$43214321
Sign in for full access
Location
Santa Barbara, California, United States, North America
Founded on
January 1, 2011
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Founders
Loriel May